APPENDIX A:

CURRICULUM VITAE FOR DR. MICHAEL D. WEST AND DISCLOSURES REGARDING ORIGEN THERAPEUTICS, INC. AND BIO

Under House Rule XI, clause 2(g)(4), non-governmental witnesses appearing before the Committee or its Subcommittees are required to include as part of their written testimony a curriculum vitae and a disclosure by source and amount of any federal grant, contract, or subcontract received by them or any entity they represent at the hearing, in the current and preceding two fiscal years. This information follows.

 

CURRICULUM VITAE: DR. MICHAEL D. WEST

Dr. West received his B.S. degree from Rensselear Polytechnic Institute in 1976, his M.S. degree in biology from Andrews University, and his Ph.D. degree from Baylor College of Medicine in 1989 studying the molecular biology of cell senescence. He has been the founder of two biotechnology companies, first Geron Corporation of Menlo Park, California and later Origen Therapeutics of South San Francisco, California. He is currently Chairman of the Board of Origen.

 

DISCLOSURE REGARDING ORIGEN

Origen Therapeutics has received no Federal grants, contracts or subcontracts during the past two fiscal years.

 

DISCLOSURE REGARDING BIO

The Biotechnology Industry Organization (BIO) has one federal grant in June, 1996. The grant was for $50,000 and it was from the Department of Energy to support BIO's Environmental Biotech '96 conference. One of the purposes of the meeting was to initiate a dialogue between companies employing environmental biotechnology and federal agencies using the technology. Sessions during the meeting focused on various issues related to the incorporation of new technologies into the federal government's environmental clean-up programs.

The grant was intended to help pay for the participation of federal officials and/or technical experts from outside of the United States developing innovative environmental treatment and pollution prevention technologies. The National Science and Technology Council co-hosted the meeting with BIO and worked with BIO and the Department of Energy to develop the agenda for the meeting.

BIO has no way of determining the number of grants, contracts, or subcontracts that our 760+ members have received from the Federal government.